Mi Jin Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mi Jin Oh has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Soo-Jeong Cho
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
4 shared publications - Bokyung Kim
Department of Internal Medicine, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Korea
3 shared publications - Kyungdo Han
Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
3 shared publications - Sang Gyun Kim
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
2 shared publications - Seunghan Lee
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
2 shared publications - Yoon Jin Choi
Center for Gastric Cancer, National Cancer Center, Goyang 10408, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 2 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3484
All-Cause and Cause-Specific Mortality by SEER Stage in Gastric Cancer: A Nationwide Population-Based Cohort Study
Background: Despite significant advances in diagnosis and treatment, gastric cancer remains a major global malignancy. This study aimed to evaluate the impact of Surveillance, Epidemiology, and End Result (SEER) stages on all-cause and cause-specific mortality in gastric cancer. Methods: This nationwide population-based cohort study analyzed data from the Cancer Public Library Database (CPLD). Patients aged ≥ 30 years diagnosed with gastric cancer between 2012 and 2019 were followed up until 31 December 2020. Cox proportional hazards models and Fine–Gray models were used to compare the risk of all-cause and cause-specific mortality based on SEER stages. The Kaplan–Meier method and cumulative incidence functions were applied to analyze cumulative incidences of all-cause and cause-specific mortality. Statistical significance was assessed using the log-rank test and Gray’s test. Additionally, a subgroup analysis was performed. Results: Among 218,491 individuals, 59,952 died during a median follow-up of 3.62 years. Compared with the localized stage, the risk of all-cause mortality was 4.31 and 24.73 times higher in patients with the regional and distant stages, respectively, after adjusting for sex, age, income, residential area, and comorbidities. The regional stage was associated with an 8.70-, 6.08-, 1.28-, and 1.43-fold higher risk of stomach cancer death, cancer death, cardiovascular death, and respiratory death, respectively. The distant stage was associated with 51.67-, 35.97-, 1.74, and 1.54-fold higher risk of stomach cancer death, cancer death, cardiovascular death, and respiratory death, respectively. Conclusions: Higher SEER stage in gastric cancer is associated with an increased risk of all-cause mortality, gastric cancer-specific mortality, overall cancer mortality, cardiovascular disease-related mortality, and respiratory disease-related mortality. Notably, cardiopulmonary mortality increased with advancing SEER stage, particularly among younger patients, underscoring the need for vigilant monitoring.
- 2 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3484
Open AccessAll-Cause and Cause-Specific Mortality by SEER Stage in Gastric Cancer: A Nationwide Population-Based Cohort Study
Background: Despite significant advances in diagnosis and treatment, gastric cancer remains a major global malignancy. This study aimed to evaluate the impact of Surveillance, Epidemiology, and End Result (SEER) stages on all-cause and cause-specific mortality in gastric cancer. Methods: This nationwide population-based cohort study analyzed data from the Cancer Public Library Database (CPLD). Patients aged ≥ 30 years diagnosed with gastric cancer between 2012 and 2019 were followed up until 31 December 2020. Cox proportional hazards models and Fine–Gray models were used to compare the risk of all-cause and cause-specific mortality based on SEER stages. The Kaplan–Meier method and cumulative incidence functions were applied to analyze cumulative incidences of all-cause and cause-specific mortality. Statistical significance was assessed using the log-rank test and Gray’s test. Additionally, a subgroup analysis was performed. Results: Among 218,491 individuals, 59,952 died during a median follow-up of 3.62 years. Compared with the localized stage, the risk of all-cause mortality was 4.31 and 24.73 times higher in patients with the regional and distant stages, respectively, after adjusting for sex, age, income, residential area, and comorbidities. The regional stage was associated with an 8.70-, 6.08-, 1.28-, and 1.43-fold higher risk of stomach cancer death, cancer death, cardiovascular death, and respiratory death, respectively. The distant stage was associated with 51.67-, 35.97-, 1.74, and 1.54-fold higher risk of stomach cancer death, cancer death, cardiovascular death, and respiratory death, respectively. Conclusions: Higher SEER stage in gastric cancer is associated with an increased risk of all-cause mortality, gastric cancer-specific mortality, overall cancer mortality, cardiovascular disease-related mortality, and respiratory disease-related mortality. Notably, cardiopulmonary mortality increased with advancing SEER stage, particularly among younger patients, underscoring the need for vigilant monitoring.
- Open Access
- 31 December 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (5) , 776-786
Increased Heart Failure Risk with Gastric Cancer Progression: A Nationwide Population-Based Cohort Study
Seunghan Lee, Mi Jin Oh , Bokyung Kim , Yoon Jin Choi, Kyungdo Han, Soo-Jeong Cho. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250209
- 31 December 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (5) , 776-786
Open AccessIncreased Heart Failure Risk with Gastric Cancer Progression: A Nationwide Population-Based Cohort Study
Seunghan Lee, Mi Jin Oh , Bokyung Kim , Yoon Jin Choi, Kyungdo Han, Soo-Jeong Cho. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250209
- Open Access
- 21 March 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (6) , 992-1001
Risk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at Helicobacter pylori Eradication
Seunghan Lee, Soo-Jeong Cho, Hyunsoo Chung, Bokyung Kim, Mi Jin Oh, Yun Suk Na, Jun Hee Lee, Jiyoon Kim, Sang Gyun Kim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230383
- 21 March 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (6) , 992-1001
Open AccessRisk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at Helicobacter pylori Eradication
Seunghan Lee, Soo-Jeong Cho, Hyunsoo Chung, Bokyung Kim, Mi Jin Oh, Yun Suk Na, Jun Hee Lee, Jiyoon Kim, Sang Gyun Kim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230383
- Open Access
- 1 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (48) , e36260
Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study
Obesity is a known risk factor for gastric cancer. However, the relationship between serum lipids and gastric cancer risk has not been fully established. We investigated the relationship between serum cholesterol levels and gastric cancer risk using a nationwide population cohort. Adults who received health care screening in 2009 from the Korean National Health Insurance Service were enrolled. Gastric cancer risk in relation to quartiles of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) were compared according to sex, using adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs). Among 9690,168 subjects enrolled, 92,403 gastric cancer cases were diagnosed. Higher HDL-C levels were associated with lower gastric cancer risk in the total population, men, and women (aHR [for the highest quartile] = 0.98 [0.96–0.99, P < .0001], aHR = 0.98 [0.96–1.004, P = .0004], and aHR = 0.91 [0.88–0.94, P < .0001], respectively). HDL-C showed consistent trends regardless of age or statin use. Higher LDL-C levels were also associated with lower gastric cancer risk in the total population (aHR = 0.92 [0.91–0.94], P < .0001) and men (aHR = 0.94 [0.91–0.96], P < .0001), but not in women (P = .4073). A subgroup analysis of LDL-C showed significant interactions with age and statin use (P interaction < .0001 and P interaction = .0497, respectively). The risk of gastric cancer was higher in subjects with elevated LDL-C levels in the younger group (age < 55, HR [for the highest quartile] = 1.02 [0.99–1.04] in the total population; HR = 1.03 [1.003–1.06] in men), the risk was lower in subjects with elevated LDL-C in the elderly (age ≥ 55, HR = 0.93 [0.91–0.95] in the total population; HR = 0.94 [0.92–0.96] in men). Elevated TC was associated with lower gastric cancer risk in the total population (aHR = 0.95 [0.94–0.97], P < .0001), but not in each sex separately (P = .3922 in men; P = .1046 in women). Overall, higher HDL-C levels may play a protective role in gastric cancer pathogenesis. The association between LDL-C/TC and gastric cancer seems to vary according to sex, age, and statin use. Especially in young males under age 55, high LDL-C and TC levels were associated with higher risk of gastric cancer.
- 1 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (48) , e36260
Open AccessRisk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study
Obesity is a known risk factor for gastric cancer. However, the relationship between serum lipids and gastric cancer risk has not been fully established. We investigated the relationship between serum cholesterol levels and gastric cancer risk using a nationwide population cohort. Adults who received health care screening in 2009 from the Korean National Health Insurance Service were enrolled. Gastric cancer risk in relation to quartiles of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) were compared according to sex, using adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs). Among 9690,168 subjects enrolled, 92,403 gastric cancer cases were diagnosed. Higher HDL-C levels were associated with lower gastric cancer risk in the total population, men, and women (aHR [for the highest quartile] = 0.98 [0.96–0.99, P < .0001], aHR = 0.98 [0.96–1.004, P = .0004], and aHR = 0.91 [0.88–0.94, P < .0001], respectively). HDL-C showed consistent trends regardless of age or statin use. Higher LDL-C levels were also associated with lower gastric cancer risk in the total population (aHR = 0.92 [0.91–0.94], P < .0001) and men (aHR = 0.94 [0.91–0.96], P < .0001), but not in women (P = .4073). A subgroup analysis of LDL-C showed significant interactions with age and statin use (P interaction < .0001 and P interaction = .0497, respectively). The risk of gastric cancer was higher in subjects with elevated LDL-C levels in the younger group (age < 55, HR [for the highest quartile] = 1.02 [0.99–1.04] in the total population; HR = 1.03 [1.003–1.06] in men), the risk was lower in subjects with elevated LDL-C in the elderly (age ≥ 55, HR = 0.93 [0.91–0.95] in the total population; HR = 0.94 [0.92–0.96] in men). Elevated TC was associated with lower gastric cancer risk in the total population (aHR = 0.95 [0.94–0.97], P < .0001), but not in each sex separately (P = .3922 in men; P = .1046 in women). Overall, higher HDL-C levels may play a protective role in gastric cancer pathogenesis. The association between LDL-C/TC and gastric cancer seems to vary according to sex, age, and statin use. Especially in young males under age 55, high LDL-C and TC levels were associated with higher risk of gastric cancer.
- Open Access
- 1 January 2018
- Published by Korean Dementia Association in Dementia and Neurocognitive Disorders
- Vol. 17 (2) , 66-70
Early Onset Alzheimer's Disease Presenting as Logopenic Primary Progressive Aphasia
- 1 January 2018
- Published by Korean Dementia Association in Dementia and Neurocognitive Disorders
- Vol. 17 (2) , 66-70
Open AccessEarly Onset Alzheimer's Disease Presenting as Logopenic Primary Progressive Aphasia
- 1 July 2017
- Published by Elsevier in Clinical Therapeutics
- Vol. 39 (7) , 1371-1379
Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects
- 1 July 2017
- Published by Elsevier in Clinical Therapeutics
- Vol. 39 (7) , 1371-1379
Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects